Clinical Trial Update: Prime-boost Vaccine Study in Women With Low-grade Cervical HPV Lesions [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial of a prime-boost vaccine for HPV-related cervical lesions in women with CIN1 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Intraepithelial Neoplasia
• Human Papillomavirus Infection

Drugs mentioned

• Prime-boost vaccine candidate

Snippet

Sponsor: Barinthus Biotherapeutics | Conditions: HPV Infection, CIN1 | Phase 1, Phase 2 | Status: COMPLETED